CDV3

Across TCGA pan-cancer cohorts, CDV3 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CDV3 data layer compared with 21 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CDV3 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CDV3 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC and UCEC are the cancer types where CDV3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.101	0.710	<.001	24	view →
UCEC	DFS	Median	All	1.000	0.633	.014	22	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CDV3–HNSC (DFS)

Open the HNSC breakdown →